| # | Drug | Count |
|---|---|---|
| 0 | ALENDRONATE SODIUM | 99 |
| 1 | DENOSUMAB | 51 |
| 2 | METHOTREXATE SODIUM | 47 |
| 3 | METHOTREXATE | 44 |
| 4 | CALCIUM | 17 |
| 5 | PREDNISOLONE | 17 |
| 6 | PREDNISOLONE ORAL | 17 |
| 7 | PREDNISOLONE ORAL SOLUTION | 17 |
| 8 | RISEDRONATE SODIUM | 17 |
| 9 | ACETAMINOPHEN | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MARSTACIMAB-HNCQ | 1 | 0.0097 |
| 1 | PRAMOXINE HYDROCHLORIDE, MENTHOL | 1 | 0.0047 |
| 2 | COLLOIDAL OATMEAL | 1 | 0.0039 |
| 3 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 9 | 0.0032 |
| 4 | PRUCALOPRIDE SUCCINATE | 1 | 0.0029 |
| 5 | IBANDRONATE SODIUM | 9 | 0.0029 |
| 6 | ALLOPURINOL SODIUM | 1 | 0.0018 |
| 7 | ALENDRONATE SODIUM | 99 | 0.0010 |
| 8 | PIOGLITAZONE AND METFORMIN HYDROCHLORIDE | 1 | 0.0008 |
| 9 | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | 2 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 56 |
| 1 | RANK Ligand Inhibitor [EPC] | 51 |
| 2 | Corticosteroid [EPC] | 44 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 43 |
| 4 | Proton Pump Inhibitor [EPC] | 23 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 21 |
| 6 | Vitamin D [EPC] | 21 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 18 |
| 8 | Calcium [EPC] | 17 |
| 9 | Vitamin C [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Calcitonin [EPC] | 1 | 0.0003 |
| 1 | RANK Ligand Inhibitor [EPC] | 51 | 0.0003 |
| 2 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 3 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 4 | Complement 5a Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Parathyroid Hormone Analog [EPC] | 14 | 0.0001 |
| 6 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 7 | Calcium [EPC] | 17 | 0.0001 |
| 8 | Antirheumatic Agent [EPC] | 12 | 0.0001 |
| 9 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |